Prosthetic joint infection

References

• Whittle J, Steinberg EP, Anderson GF, Herbert R, Hochberg MC. Mortality after elective total hip arthroplasty in elderly Americans. Age, gender, and indication for surgery predict survival. Clin. Orthop. Relat. Res. 295, 119–126 (1993).
   PubMed Web of Science ®Google Scholar
• Bozic KJ, Kinder J, Menegini M et al. Implant survivorship and complication rates after total knee arthroplasty with a third-generation cemented system: 5 to 8 years follow-up. Clin. Orthop. Relat. Res. 430, 117–124 (2005).
   Web of Science ®Google Scholar
• Darouiche RO. Treatment of infections associated with surgical implants. N. Engl. J. Med. 350, 1422–1429 (2004).
   PubMed Web of Science ®Google Scholar
• Berbari EF, Hanssen AD, Duffy MC et al. Risk factors for prosthetic joint infection: case-control study. Clin. Infect. Dis. 27, 1247–1254 (1998).
   PubMed Web of Science ®Google Scholar
• Hanssen AD, Rand JA. Evaluation and treatment of infection at the site of a total hip or knee arthroplasty. Instr. Course Lect. 48, 111–122 (1999).
   PubMedGoogle Scholar
• Cofield RH. Uncemented total shoulder arthroplasty. A review. Clin. Orthop. Relat. Res. 307, 86–93 (1994).
   PubMed Web of Science ®Google Scholar
• Hofmann AA, Goldberg T, Tanner AM, Kurtin SM. Treatment of infected total knee arthroplasty using an articulating spacer: 2- to 12-year experience. Clin. Orthop. Relat. Res. 430, 125–131 (2005).
   PubMedGoogle Scholar
• Dubost JJ, Soubrier M, De Champs C et al. No changes in the distribution of organisms responsible for septic arthritis over a 20 year period. Ann. Rheum. Dis. 61, 267–269 (2002).
   PubMed Web of Science ®Google Scholar
• Spinner RJ, Sexton DJ, Goldner RD, Levin LS. Periprosthetic infections due to Mycobacterium tuberculosis in patients with no prior history of tuberculosis. J. Arthroplasty 11, 217–222 (1996).
   PubMed Web of Science ®Google Scholar
• Lerch K, Kalteis T, Schubert T, Lehn N, Grifka J. Prosthetic joint infections with osteomyelitis due to Candida albicans. Mycoses 46, 462–466 (2003).
   PubMed Web of Science ®Google Scholar
• Weil Y, Mattan Y, Liebergall M, Rahav G. Brucella prosthetic joint infection: a report of 3 cases and a review of the literature. Clin. Infect. Dis. 36, E81–E86 (2003).
   PubMed Web of Science ®Google Scholar
• Riede U, Graber P, Ochsner PE. Granulicatella (Abiotrophia) adiacens infection associated with a total knee arthroplasty. Scand. J. Infect. Dis. 36, 761–764 (2004).
   PubMed Web of Science ®Google Scholar
• Panackal AA, Houze YB, Prentice J et al. Prosthetic joint infection due to ‘Helcococcus pyogenica’. J. Clin. Microbiol. 42, 2872–2874 (2004).
   PubMed Web of Science ®Google Scholar
• Perkins S, Walsh EJ, Deivanayagam CCS et al. Structural organization of the fibrinogen-binding region of the clumping factor B MSCRAMM of Staphylococcus aureus. J. Biol. Chem. 276, 44721–44728 (2001).
   PubMed Web of Science ®Google Scholar
• Leid JG, Shirtliff ME, Costerton JW, Stoodley AP. Human leukocytes adhere to, penetrate, and respond to Staphylococcus aureus biofilms. Infect. Immun. 70, 6339–6345 (2002).
   PubMed Web of Science ®Google Scholar
• Gotz F. Staphylococcus and biofilms. Mol. Microbiol. 43, 1367–1378 (2002).
   PubMed Web of Science ®Google Scholar
• Trampuz A, Osmon DR, Hanssen AD, Steckelberg JM, Patel R. Molecular and antibiofilm approaches to prosthetic joint infection. Clin. Orthop. Relat. Res. 414, 69–88 (2003).
   PubMed Web of Science ®Google Scholar
• Wymenga AB, van Horn JR, Theeuwes A, Muytjens HL, Slooff TJ. Perioperative factors associated with septic arthritis after arthroplasty. Prospective multicenter study of 362 knee and 2,651 hip operations. Acta Orthop. Scand. 63, 665–671 (1992).
   PubMed Web of Science ®Google Scholar
• Silva M, Luck JV Jr. Long-term results of primary total knee replacement in patients with hemophilia. J. Bone Joint Surg. Am. 87, 85–91 (2005).
   PubMedGoogle Scholar
• Ahnfelt L, Herberts P, Malchau H, Andersson GB. Prognosis of total hip replacement. A Swedish multicenter study of 4,664 revisions. Acta. Orthop. Scand. 238(Suppl.), 1–26 (1990).
   Google Scholar
• Hoekman P, van de Perre P, Nelissen J et al. Increased frequency of infection after open reduction of fractures in patients who are seropositive for human immunodeficiency virus. J. Bone Joint Surg. Am. 73, 675–679 (1991).
   PubMedGoogle Scholar
• Jellis JE. Orthopaedic surgery and HIV disease in Africa. Int. Orthop. 20, 253–256 (1996).
   PubMed Web of Science ®Google Scholar
• Harrison WJ, Lewis CP, Lavy CB. Wound healing after implant surgery in HIV-positive patients. J. Bone Joint Surg. Br. 84, 802–806 (2002).
   PubMedGoogle Scholar
• Coventry MB. Treatment of infections occurring in total hip surgery. Orthop. Clin. North Am. 6, 991–1003 (1975).
   PubMed Web of Science ®Google Scholar
• Widmer AF. New developments in diagnosis and treatment of infection in orthopedic implants. Clin. Infect. Dis. 33(Suppl. 2), S94–S106 (2001).
   PubMed Web of Science ®Google Scholar
• Schmalzried TP, Amstutz HC, Au MK, Dorey FJ. Etiology of deep sepsis in total hip arthroplasty. The significance of hematogenous and recurrent infections. Clin. Orthop. Relat. Res. 280, 200–207 (1992).
   Google Scholar
• Hanssen A, Osmon D. Prevention of prosthetic joint infection. In: Joint Replacement Arthroplasty. Bernard FM (Ed.). Churchill Livingstone, PA, USA, 79–91 (2003).
   Google Scholar
• Lachiewicz PF, Rogers GD, Thomason HC. Aspiration of the hip joint before revision total hip arthroplasty. Clinical and laboratory factors influencing attainment of a positive culture. J. Bone Joint Surg. Am. 78, 749–754 (1996).
   PubMedGoogle Scholar
• Duff GP, Lachiewicz PF, Kelley SS. Aspiration of the knee joint before revision arthroplasty. Clin. Orthop. Relat. Res. 331, 132–139 (1996).
   Google Scholar
• Bernard L, Lubbeke A, Stern R et al. Value of preoperative investigations in diagnosing prosthetic joint infection: retrospective cohort study and literature review. Scand. J. Infect. Dis. 36, 410–416 (2004).
   PubMed Web of Science ®Google Scholar
• Spangehl MJ, Masri BA, O’Connell JX, Duncan CP. Prospective analysis of preoperative and intraoperative investigations for the diagnosis of infection at the sites of two hundred and two revision total hip arthroplasties. J. Bone Joint Surg. Am. 81, 672–683 (1999).
   PubMed Web of Science ®Google Scholar
• Sanzen L, Carlsson AS. The diagnostic value of C-reactive protein in infected total hip arthroplasties. J. Bone Joint Surg. Br. 71, 638–641 (1989).
   PubMedGoogle Scholar
• Trampuz A, Hanssen AD, Osmon DR et al. Synovial fluid leukocyte count and differential for the diagnosis of prosthetic knee infection. Am. J. Med. 117, 556–562 (2004).
   PubMed Web of Science ®Google Scholar
• Santavirta S, Konttinen YT, Nordstrom D et al. Immune-inflammatory response in infected arthroplasties. Acta Orthop. Scand. 60, 116–118 (1989).
   PubMed Web of Science ®Google Scholar
• Spangehl MJ, Younger AS, Masri BA, Duncan CP. Diagnosis of infection following total hip arthroplasty. Instr. Course Lect. 47, 285–295 (1998).
   PubMedGoogle Scholar
• Stumpe KDM, Notzli HP, Zanetti M et al. FDG PET for differentiation of infection and aseptic loosening in total hip replacements: comparison with conventional radiography and three-phase bone scintigraphy. Radiology 231, 333–341 (2004).
   PubMed Web of Science ®Google Scholar
• Rabin D, Smith C, Kubicka R et al. Problem prostheses: the radiologic evaluation of total joint replacement. Radiographics 7, 1107–1127 (1987).
   PubMedGoogle Scholar
• Cyteval C, Hamm V, Sarrabere MP et al. Painful infection at the site of hip prosthesis: CT imaging. Radiology 224, 477–483 (2002).
   PubMed Web of Science ®Google Scholar
• Love C, Tomas MB, Marwin SE, Pugliese PV, Palestro CJ. Role of nuclear medicine in diagnosis of the infected joint replacement. Radiographics 21, 1229–1238 (2001).
   PubMed Web of Science ®Google Scholar
• Love C, Marwin SE, Tomas MB et al. Diagnosing infection in the failed joint replacement: a comparison of coincidence detection 18F-FDG and 111In-labeled leukocyte/99mTc-sulfur colloid marrow imaging. J. Nucl. Med. 45, 1864–1871 (2004).
   PubMed Web of Science ®Google Scholar
• Atkins BL, Athanasou N, Deeks JJ et al. Prospective evaluation of criteria for microbiological diagnosis of prosthetic-joint infection at revision arthroplasty. The OSIRIS Collaborative Study Group. J. Clin. Microbiol. 36, 2932–2939 (1998).
   PubMed Web of Science ®Google Scholar
• Tunney MM, Patrick S, Gorman SP et al. Improved detection of infection in hip replacements. A currently underestimated problem. J. Bone Joint Surg. Br. 80, 568–572 (1998).
   PubMedGoogle Scholar
• Lonner JH, Desai P, Dicesare PE, Steiner G, Zuckerman JD. The reliability of analysis of intraoperative frozen sections for identifying active infection during revision hip or knee arthroplasty. J. Bone Joint Surg. Am. 78, 1553–1558 (1996).
   PubMed Web of Science ®Google Scholar
• Levine MJ, Mariani BA, Tuan RS, Booth RE Jr. Molecular genetic diagnosis of infected total joint arthroplasty. J. Arthroplasty 10, 93–94 (1995).
   PubMedGoogle Scholar
• Hoeffel DP, Hinrichs SH, Garvin KL. Molecular diagnostics for the detection of musculoskeletal infection. Clin. Orthop. Relat. Res. 360, 37–46 (1999).
   PubMed Web of Science ®Google Scholar
• van der Heijden IM, Wilbrink B, Schouls LM et al. Detection of mycobacteria in joint samples from patients with arthritis using a genus-specific polymerase chain reaction and sequence analysis. Rheumatology 38, 547–553 (1999).
   PubMed Web of Science ®Google Scholar
• van der Heijden IM, Wilbrink B, Vije AE et al. Detection of bacterial DNA in serial synovial samples obtained during antibiotic treatment from patients with septic arthritis. Arthritis Rheum. 42, 2198–2203 (1999).
   PubMedGoogle Scholar
• Tsukayama DT, Wicklund B, Gustilo RB. Suppressive antibiotic therapy in chronic prosthetic joint infections. Orthopedics 14, 841–844 (1991).
   PubMed Web of Science ®Google Scholar
• Fisman DN, Reilly DT, Karchmer AW, Goldie SJ. Clinical effectiveness and cost–effectiveness of 2 management strategies for infected total hip arthroplasty in the elderly. Clin. Infect. Dis. 32, 419–430 (2001).
   PubMed Web of Science ®Google Scholar
• Crockarell JR, Hanssen AD, Osmon DR, Morrey BF. Treatment of infection with debridement and retention of the components following hip arthroplasty. J. Bone Joint Surg. Am. 80, 1306–1313 (1998).
   PubMed Web of Science ®Google Scholar
• Tsukayama DT, Estrada R, Gustilo RB. Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections. J. Bone Joint Surg. Am. 78, 512–523 (1996).
   PubMed Web of Science ®Google Scholar
• Trebse R, Pisot V, Trampuz A. Treatment of infected retained implants. J. Bone Joint Surg. Br. 87, 249–256 (2005).
   PubMedGoogle Scholar
• Jackson WO, Schmalzried TP. Limited role of direct exchange arthroplasty in the treatment of infected total hip replacements. Clin. Orthop. Relat. Res. 381, 101–105 (2000).
   Google Scholar
• Buechel FF, Femino FP, D’Alessio J. Primary exchange revision arthroplasty for infected total knee replacement: a long-term study. Am. J. Orthop. 33, 190–198 (2004).
   PubMedGoogle Scholar
• Ure KJ, Amstutz HC, Nasser S, Schmalzried TP. Direct-exchange arthroplasty for the treatment of infection after total hip replacement. An average ten-year follow-up. J. Bone Joint Surg. Am. 80, 961–968 (1998).
   PubMed Web of Science ®Google Scholar
• Insall JN, Thompson FM, Brause BD. Two-stage reimplantation for the salvage of infected total knee arthroplasty. J. Bone Joint Surg. Am. 65, 1087–1098 (1983).
   PubMed Web of Science ®Google Scholar
• Windsor RE, Insall JN, Urs WK, Miller DV, Brause BD. Two-stage reimplantation for the salvage of total knee arthroplasty complicated by infection. Further follow-up and refinement of indications. J. Bone Joint Surg. Am. 72, 272–278 (1990).
   PubMed Web of Science ®Google Scholar
• Bittar ES, Petty W. Girdlestone arthroplasty for infected total hip arthroplasty. Clin. Orthop. Relat. Res. 83–87 (1982).
   PubMedGoogle Scholar
• Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N. Engl. J. Med. 351, 1645–1654 (2004).
   PubMed Web of Science ®Google Scholar
• Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. J. Am. Med. Assoc. 279, 1537–1541 (1998).
   PubMed Web of Science ®Google Scholar
• Drancourt M, Stein A, Argenson JN et al. Oral rifampin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implants. Antimicrob. Agents Chemother. 37, 1214–1218 (1993).
   PubMed Web of Science ®Google Scholar
• Drancourt M, Stein A, Argenson JN et al. Oral treatment of Staphylococcus spp. infected orthopaedic implants with fusidic acid or ofloxacin in combination with rifampicin. J. Antimicrob. Chemother. 39, 235–240 (1997).
   PubMed Web of Science ®Google Scholar
• Stein A, Bataille JF, Drancourt M et al. Ambulatory treatment of multi-drug resistant Staphylococcus-infected orthopedic implants with high-dose oral co-trimoxazole (trimethoprim-sulfamethoxazole). Antimicrob. Agents Chemother. 42, 3086–3091 (1998).
   PubMed Web of Science ®Google Scholar
• Bassetti M, Vitale F, Melica G et al. Linezolid in the treatment of Gram-positive prosthetic joint infections. J. Antimicrob. Chemother. 55, 387–390 (2005).
   PubMed Web of Science ®Google Scholar
• Razonable RR, Osmon DR, Steckelberg JM. Linezolid therapy for orthopedic infections. Mayo. Clin. Proc. 79, 1137–1144 (2004).
   PubMed Web of Science ®Google Scholar
• Fong IW, Ledbetter WH, Vandenbroucke AC, Simbul M, Rahm V. Ciprofloxacin concentrations in bone and muscle after oral dosing. Antimicrob. Agents Chemother. 29, 405–408 (1986).
   PubMed Web of Science ®Google Scholar
• Carlsson AS, Josefsson G, Lindberg L. Revision with gentamicin-impregnated cement for deep infections in total hip arthroplasties. J. Bone Joint Surg. Am. 60, 1059–1064 (1978).
   PubMed Web of Science ®Google Scholar
• Henry SL, Galloway KP. Local antibacterial therapy for the management of orthopaedic infections. Pharmacokinetic considerations. Clin. Pharmacokinet. 29, 36–45 (1995).
   PubMed Web of Science ®Google Scholar
• Anguita-Alonso P, Hanssen A, Osmon D et al. High rate of aminoglycoside resistance amongst Staphylococci causing prosthetic joint infection. Clin. Orthop. (2005) (In Press).
   Google Scholar
• Lidwell OM. Clean air at operation and subsequent sepsis in the joint. Clin. Orthop. Relat. Res. 211, 91–102 (1986).
   Google Scholar
• Bourne RB. Prophylactic use of antibiotic bone cement: an emerging standard-in the affirmative. J. Arthroplasty 19, 69–72 (2004).
   PubMed Web of Science ®Google Scholar
• Engesaeter LB, Lie SA, Espehaug B et al. Antibiotic prophylaxis in total hip arthroplasty: effects of antibiotic prophylaxis systemically and in bone cement on the revision rate of 22,170 primary hip replacements followed 0–14 years in the Norwegian Arthroplasty Register. Acta Orthop. Scand. 74, 644–651 (2003).
   PubMed Web of Science ®Google Scholar
• Hanssen A. Prophylactic use of antibiotic bone cement: an emerging standard-in opposition (1). J. Arthroplasty 19, 73–77 (2004).
   PubMed Web of Science ®Google Scholar
• Antibiotic prophylaxis for dental patients with total joint replacements. J. Am. Dent. Assoc. 134, 895–899 (2003).
   PubMed Web of Science ®Google Scholar